Drug Discovery Automation: High-content Screening & Cell Based Assays

Agenda Topics

• Advances in HCA Miniaturization: From Hardware to Software
• Applications of HCS in Drug Toxicity, Safety and Pollution Assessment
• HCS Based RNAi Target Validation and Biomarker Discovery
• Novel Reagents and Probes for use in High Content Assay Development
• Use of Primary Cells in High Content Screening

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

, ,
, ,
Nathalie Aulner, Senior Researcher, Institut Pasteur
Chris Bakal, Dynamical Cell Systems Team Leader, Institute of Cancer Research
Stephen Brown, RNAi Facility Screening Manager, Sheffield University
Frank Buchholz, Professor, University of Technology Dresden
Jan de Sonneville, CEO, Life Science Methods B.V.
Robin Ketteler, Group Leader/Manager, University College London
Janos Kriston-Vizi, Investigator Scientist, University College London
Urban Liebel, Group Leader/Head, Karlsruhe Institute of Technology
Matthias Nees, Principal Scientist, VTT Technical Research Centre
Huib Ovaa, Group Leader, Netherlands Cancer Institute
Stephan Schurer, Assistant Professor, University of Miami
Emma Shanks, Head of Screening, Beatson Institute for Cancer Research
Krister Wennerberg, Group Leader, Institute for Molecular Medicine Finland